Phase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b in human adult volunteers

Article

Abstract: Since 1989, we have been involved in the development of a vaccine against Haemophilus influenzae typ

Palabras claves:

Autores:

Aguilar A., Alvarez Y., Baly A., Dfana J., Diaz M., Eugenio Hardy, Fernández-Santana V., Hernandez H., Hernández I., Heynngnezz L., Musachio A., Muzio V., Rodriguez A., Rodriguez F., Rodriguez M.C., Sánchez R., Serrano T., Toledo-Romani M.E., Toraño G., Verez-Bencomo V.

Fuentes:

scopus